About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Eif4ebp1tm1Nso
targeted mutation 1, Nahum Sonenberg
MGI:2177923
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso involves: 129S4/SvJae * BALB/c MGI:3618868
hm2
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso involves: 129S4/SvJae * C57BL/6 MGI:5810171
cn3
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Rhebtm1.1Otsu/Rhebtm1.1Otsu
Tg(Myh6-cre)2182Mds/0
involves: 129 * C57BL/6J * FVB/N MGI:5502748
cn4
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Mtortm1.1Gcon/Mtortm1.1Gcon
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S4/SvJae * C57BL/6 * FVB/N MGI:5810178


Genotype
MGI:3618868
hm1
Allelic
Composition
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Genetic
Background
involves: 129S4/SvJae * BALB/c
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eif4ebp1tm1Nso mutation (2 available); any Eif4ebp1 mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
adipose tissue
• at 10-12 months, homozygotes exhibit a normal food intake but show a ~60% reduction in overall WAT weight
• in contrast, intercapsular BAT weight and heart weight remains unaffected
• at 10-12 months, male and female homozygotes exhibit reduced adipose tissue mass relative to wild-type counterparts
• at 10-12 months, male homozygotes display 35% of wild-type reproductive fat pad weights
• however, no differences in epididynal WAT histology are observed
• at 10-12 months, male and female homozygotes display 42% and 53% of wild-type inguinal fat pad weights, respectively
• in males, the inguinal WAT displays the characteristic multilocular appearance of brown adipocytes, and shows a ~6-fold increase in mRNA expression of UCP1, a specific marker of brown fat
• at 10-12 months, male and female homozygotes display 36% and 53% of wild-type retroperitoneal fat pad weights, respectively
• in males, the retroperitoneal WAT displays the characteristic multilocular appearance of brown adipocytes
• male homozygotes display histologic, physiologic and molecular features of brown adipocytes in their inguinal WAT, including upregulation of UCP1 expression and increased protein levels of a transcriptional co-activator implicated in mitochondrial biogenesis and adaptive thermogenesis

homeostasis/metabolism
• homozygotes are viable, fertile, and developmentally normal with no signs of illness or tumor formation
• however, homozygotes exhibit a ~15% reduction in fed and fasted glycemia, despite normal plasma insulin levels
• male homozygotes show a 60% reduction in circulating leptin levels relative to wild-type males
• in contrast, circulating triglyceride levels remain unaffected
• male homozygotes exhibit a ~15% increase in their metabolic rate (ml 02/kg/h) relative to wild-type males
• in contrast, female homozygotes show a normal metabolic rate relative to wild-type females

growth/size/body
• at 9-10 weeks, male homozygotes show a normal linear (nose-anus) growth; however, mutant males display a ~10% reduction in body weight relative to wild-type males

cellular
• mutant MEFs exhibit increased eIF4E phosphorylation relative to wild-type MEFs




Genotype
MGI:5810171
hm2
Allelic
Composition
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eif4ebp1tm1Nso mutation (2 available); any Eif4ebp1 mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• hearts show improved baseline inotropy and lusitropy and improved reactivity to stimulation with increasing units of dobutamine relative to control mice
• cultured adult cardiomyocytes show significantly enhanced protein synthesis relative to controls, as assessed by a [3H]leucine uptake assay

muscle
• hearts show improved baseline inotropy and lusitropy and improved reactivity to stimulation with increasing units of dobutamine relative to control mice




Genotype
MGI:5502748
cn3
Allelic
Composition
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Rhebtm1.1Otsu/Rhebtm1.1Otsu
Tg(Myh6-cre)2182Mds/0
Genetic
Background
involves: 129 * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eif4ebp1tm1Nso mutation (2 available); any Eif4ebp1 mutation (33 available)
Rhebtm1.1Otsu mutation (0 available); any Rheb mutation (26 available)
Tg(Myh6-cre)2182Mds mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• improved survival compared to in Rhebtm1.1Otsu/Rhebtm1.1Otsu Tg(Myh6-cre)2182Mds mice

cardiovascular system
N
• mice exhibit improved cardiac function, hypertrophic growth and sarcomere maturation compared with Rhebtm1.1Otsu/Rhebtm1.1Otsu Tg(Myh6-cre)2182Mds mice




Genotype
MGI:5810178
cn4
Allelic
Composition
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Mtortm1.1Gcon/Mtortm1.1Gcon
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Eif4ebp1tm1Nso mutation (2 available); any Eif4ebp1 mutation (33 available)
Mtortm1.1Gcon mutation (1 available); any Mtor mutation (115 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• after tamoxifen (TMX) treatment, mice exhibit significantly enhanced survival relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice

cardiovascular system
N
• at 4 weeks after TMX treatment, mice exhibit normal echocardiographic parameters, cardiomyocyte size, and cardiac function (as assessed by the LV fractional shortening %)
• at 4 weeks after TMX treatment, mice show significantly reduced fibrosis relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice
• at 4 weeks after TMX treatment, mice show a significant decrease of cleaved Parp protein and TUNEL+ cells in the myocardium relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice

cellular
• at 4 weeks after TMX treatment, mice show significantly reduced fibrosis relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice
• at 4 weeks after TMX treatment, mice show a significant decrease of cleaved Parp protein and TUNEL+ cells in the myocardium relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice
• after TMX treatment, mice show a similar expression of autophagy genes relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice, suggesting that autophagy is not involved in the amelioration of the heart failure phenotype
• at 4 weeks after TMX treatment, mice show increased cytochrome c oxidase subunit IV (CoxIV) expression in heart lysates relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice, suggesting that mitochondrial function is improved

muscle
• at 4 weeks after TMX treatment, mice show a significant decrease of cleaved Parp protein and TUNEL+ cells in the myocardium relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice

homeostasis/metabolism
• after TMX treatment, mice show a similar expression of autophagy genes relative to Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/0 mice, suggesting that autophagy is not involved in the amelioration of the heart failure phenotype





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory